Vnitr Lek 2009, 55(3):184-186

The use of adult human bone marrow stem cells in the treatment of spinal injury

Š. Fedorko*, R. Lipina
Neurochirurgická klinika FN Ostrava, přednosta prim. MUDr. Tomáš Paleček, Ph.D.

The spectrum of stem cells therapeutic uses broadens with advancing knowledge about this biological material. Treatment of spinal injury is one of the areas of stem cell use. Many pre-clinical studies have shown that some cells can, for example, transdifferentiate into neuronal cells and replace those that are damaged. Through secretion of many growth and neuroprotective factors, stem cells prevent, to some extent, progressive cell death, form an environment suitable for regeneration of damaged tissue, facilitate neovascularization, remyelinization etc., and in consequence may improve post-spinal injury neurological deficit. Several clinical studies have been conducted using stem cells in the treatment of spinal injury. The present paper provides a brief overview of potential uses of stem cells in spinal injury treatment.

Keywords: stem cells; spinal injury; therapy of spinal injury

Received: February 9, 2009; Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fedorko Š, Lipina R. The use of adult human bone marrow stem cells in the treatment of spinal injury. Vnitr Lek. 2009;55(3):184-186.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. http://www.spinalcord.uab.edu.
    2. Bauchet L, Lonjon N, Perrin FE et al. Strategies for spinal cord repair after injury: A review of the literature and information. Ann Readapt Med Phys 2008. Available from: doi: 10.1016/jannrmp.2008.10.0004.
    3. Bracken MB, Shepard MJ, Holford TR et al. Administration of methylprednisolone for 24 or 48 hours or tirilizad mesylate for 48 hours in the treatment of acute spinal cord injury. JAMA 1997; 277: 1597-1604. Go to original source...
    4. Bracken MB, Shepard MJ, Holford TR et al. Methylprednisolone or tirilizad mesylate administration after acute spinal cord injury: 1-year follow-up. J Neurosurg 1998; 89: 699-706. Go to original source... Go to PubMed...
    5. Fehlings MG, Perrin RG. The Timing of Surgical Intervention in the Treatment of Spinal Cord Injury: A Systematic Review of Recent Clinical Evidence. Spine 2006; 31 (Suppl 2006). Go to original source... Go to PubMed...
    6. Bracken MB, Shepard MJ, Collins WF et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinalcord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990; 322: 1405-1411. Go to original source... Go to PubMed...
    7. Sanchez-Ramos J, Song S, Cardozo-Pelaez F et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 2000; 164: 247-256. Go to original source... Go to PubMed...
    8. Woodbury D, Schwarz EJ, Prockop DJ. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000; 61: 364-370. Go to original source... Go to PubMed...
    9. Muñoz-Elías G, Woodbury D, Black IB. Marrow stromal cells, mitosis, and neuronal differentiation: stem cell and precursor functions. Stem Cells 2003; 21: 437-448. Go to original source... Go to PubMed...
    10. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49. Go to original source... Go to PubMed...
    11. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 1999; 96: 10711-10716. Go to original source... Go to PubMed...
    12. Mezey E, Chandross KJ, Harta G et al. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000; 290: 1672-1674. Go to original source... Go to PubMed...
    13. Akiyama Y, Radtke C, Honmou O et al. Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia 2002; 39: 229-236. Go to original source... Go to PubMed...
    14. Horwitzi EM, Dominici M. How do mesenchymal stromal cells exert their therapeutic benefit. Cytotherapy 2008; 10: 771-774. Go to original source... Go to PubMed...
    15. Gage FH. Mammalian neural stem cells. Science 2000; 287: 1433-1438. Go to original source... Go to PubMed...
    16. Ay H, Ay I, Koroshetz WJ et al. Potential usefulness of basic fibroblast growth factor as a treatment for stroke. Cerebrovasc Dis 1999; 9: 131-135. Go to original source... Go to PubMed...
    17. Mocchetti I, Wrathall JR. Neurotrophic factors in central nervous system trauma. J Neurotrauma 1995; 12: 853-870. Go to original source... Go to PubMed...
    18. Corti, S, Locatelli F, Strazzer S et al. Modulated generation of neuronal cells from bone marrow by expansion and mobilization of circulating stem cells with in vivo cytokine treatment. Exp Neurol 2002; 177: 443-452. Go to original source... Go to PubMed...
    19. DeKosky ST, Goss JR, Miller PD et al. Upregulation of nerve growth factor following cortical trauma. Exp Neurol 1994; 130: 173-177. Go to original source... Go to PubMed...
    20. Cheng H, Wu JP, Tzeng SF. Neuroprotection of glial cell line-derived neurotrophic factor in damaged spinal cords following contusive injury. J Neurosci Res 2002; 69: 397-405. Go to original source... Go to PubMed...
    21. Takahashi T, Kalka, Masuda C et al. Ischemia and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438. Go to original source... Go to PubMed...
    22. Lie DC, Dziewczapolski G, Willhoite AR et al. The adult substantia nigra contains progenitor cells with neurogenic potential. J Neurosci 2002; 22: 6639-6649. Go to original source... Go to PubMed...
    23. Hermann DM, Kilic E, Kugler S et al. Adenovirus-mediated glial cell line-derived neurotrophic factor (GDNF) expression protects against subsequent cortical cold injury in rats. Neurobiol 2001; 8: 964-973. Go to original source... Go to PubMed...
    24. Koda M, Nishio Y, Kamada T et al. Granulocyte colony-stimulating factor (g-csf) mobilizes bone marrowderived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice. Brain Res 2007; 1149: 223-231. Go to original source... Go to PubMed...
    25. Urdzikova L, Jendelova P, Glogarova K et al. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma 2006; 23: 1379-1391. Go to original source... Go to PubMed...
    26. Cheng H, Wu JP, Tzeng SF. Neuroprotection of glial cell line-derived neurotrophic factor in damaged spinal cords following contusive injury. J Neurosci Res 2002; 69: 397-405. Go to original source... Go to PubMed...
    27. Bouhy D, Malgrange B, Multon S et al. Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages. FASEB J 2006; 20: 1239-1241. Go to original source... Go to PubMed...
    28. Inoue S, Popp FC, Koehl GE et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 2006; 81: 1589-1595. Go to original source... Go to PubMed...
    29. Wang JW, Liu YB, Xu B et al. The study on immunomodulation of donor mesenchymal stem cells on discordant liver xenotransplantation. Chin J Surg 2005; 43: 1254-1258. Go to PubMed...
    30. Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42-48. Go to original source... Go to PubMed...
    31. Zurita M, Vaquero J. Bone marrow stromal cells can achieve cure of chronic paraplegic rats: functional and morphological outcome one year after transplantation. Neurosci Lett 2006; 402: 51-56. Go to original source... Go to PubMed...
    32. Callera F, do Nascimento RX. Delivery of autologous bone marrow precursor cells into the spinal cord via lumbar puncture technique in patients with spinal cord injury: a preliminary safety study. Exp Hematol 2006; 34: 130-131. Go to original source... Go to PubMed...
    33. Saito F, Nakatani T, Iwase M et al. Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report. J Trauma 2008; 64: 53-59. Go to original source... Go to PubMed...
    34. Deda H, Inci MC, Kürekçi AE et al. Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up. Cytotherapy 2008; 10: 565-574. Go to original source... Go to PubMed...
    35. Chernykh ER, Stupak VV, Muradov GM et al. Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients. Bull Exp Biol Med 2007; 143: 543-547. Go to original source... Go to PubMed...
    36. Kang KS, Kim SW, Oh YH et al. A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy 2005; 7: 368-373. Go to original source... Go to PubMed...
    37. Mehta T, Feroz A, Thakkar U et al. Subarachnoid placement of stem cells in neurological disorders. Transplant Proc 2008; 40: 1145-1147. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.